QQ客服 官方微博 反馈留言

	Broad RTK-targeted therapy overcomes molecular heterogeneity-driven resistance to cetuximab via vectored immunoprophylaxis in colorectal cancer
	Hu, Shi; Dai, Haibin; Li, Tian; Tang, Ying; Fu, Wenyan; Yuan, Qingning; Wang, Feifei; Lv, Gaojian; Lv, Yuanyuan; Fan, Xiaoyan
刊名	CANCER LETTERS
	2016
卷号	382期号:1
关键词	Acquire resistance CRC Viral vectors Broad targeted therapy
ISSN号	0304-3835
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4285211
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Hu, Shi,Dai, Haibin,Li, Tian,et al. Broad RTK-targeted therapy overcomes molecular heterogeneity-driven resistance to cetuximab via vectored immunoprophylaxis in colorectal cancer[J]. CANCER LETTERS,2016,382(1).
APA	Hu, Shi.,Dai, Haibin.,Li, Tian.,Tang, Ying.,Fu, Wenyan.,...&Lei, Changhai.(2016).Broad RTK-targeted therapy overcomes molecular heterogeneity-driven resistance to cetuximab via vectored immunoprophylaxis in colorectal cancer.CANCER LETTERS,382(1).
MLA	Hu, Shi,et al."Broad RTK-targeted therapy overcomes molecular heterogeneity-driven resistance to cetuximab via vectored immunoprophylaxis in colorectal cancer".CANCER LETTERS 382.1(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。